MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Fighting Freezing of gait in Parkinson’s disease: Effect of a phase-dependent tactile biofeedback

    M. Mancini, K. Smulders, G. Harker, A.C. Fortaleza, J.G. Nutt, F.B. Horak (Portland, OR, USA)

    Objective: To investigate the effect of tactile biofeedback during every stance phase on freezing of gait (FoG) in Parkinson's disease (PD). Background: Accumulating evidence suggests…
  • 2016 International Congress

    Novel training based on declarative memory cues improves gait perfromance in patients with Parkinson’s disease: A randomized clinical trial

    M.E.P. Piemonte, E. Okamoto, K.R. Cardoso, T.P. Oliveira, C.S. Miranda, M. Pikel, F. Mendes, G.F. Xavier (Sao Paulo, Brazil)

    Objective: To verify the long-term efficiency of a new strategy based on declarative memory cues to improve the gait performance and independence in activities of…
  • 2016 International Congress

    Creativity related to dopaminergic treatment. A multicenter study

    P.J. Garcia Ruiz, J.C. Martinez Castrillo, L. Vela (Madrid, Spain)

    Objective: To study patients with Parkinson´s disease (PD) and enhanced creativity related to dopaminergic therapy. Background: Impulse control disorders (ICD) including pathological gambling, hypersexuality, and…
  • 2016 International Congress

    Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease

    S. Luo, J. Wang (Houston, TX, USA)

    Objective: To develop methods for model-based personalized dynamic prediction of future outcome measure trajectories and risks of target events for the Parkinson's disease patients. Background:…
  • 2016 International Congress

    Development of a nanoherbaceutical formulation containing compound extracts from huperzia serrata, mucuna pruriens and withania somnifera for the prevention and treatment of Parkinson’s disease

    V. Kumar, P.C. Bhatt (Allahabad, India)

    Objective: We developed the nanoherbaceutical formulation and evaluated against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinson's disease (PD) model. Background: PD is a progressive neurodegenerative disorder allied…
  • 2016 International Congress

    Effect of repeated intravenous amantadine infusions in patients with Parkinson’s disease

    A. Khlebtovsky, I. Steiner, R. Djaldetti, T. Treves (Petach Tikva, Israel)

    Objective: To examine the long-term effect of repeated boosts of intravenous amantadine in patients with PD with and without response fluctuations and dyskinesias. Background: Amantadine…
  • 2016 International Congress

    A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences

    R. Korn, H.T. Keenan, T. Felong, S. Goldenthal, S. Kanchana, H. Schwarz, S. Sharma, K. Andrzejewski, E.A. Stevenson, R. Barbano, G. Kang, K. Rizer, A. Shukla, M.J. Dodge, C. Tanner, M. Katz, R. Rodriguez, N. Galifianakis, W. Zhu (Rochester, NY, USA)

    Objective: RACE-PD is a case series that aims to assess the feasibility and utility of a national program providing individuals with Parkinson's disease (PD) a…
  • 2016 International Congress

    Effectivity and safety of rotigotine transdermal patch on motor and cognitive dysfunctions in Parkinson’s disease with dementia and dementia with Lewy bodies

    K. Ohta, Y. Kujuro, T. Osada, T. Toguchi, Y. Shinohara (Tokyo, Japan)

    Objective: This study aimed to demonstrate effectivity and safety of rotigotine transdermal patch (RTP) on motor and cognitive dysfunctions in patients with Parkinson's disease with…
  • 2016 International Congress

    Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists

    S. Xu, J. Liu, X. Yang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate the association between dopamine receptor D types 2(DRD2) (CA)n and types 3 (DRD3) Ser9Gly polymorphisms and the risk of Parkinson's disease (PD),…
  • 2016 International Congress

    Medicinal cannabis for Parkinson’s disease: A survey of practices, beliefs, and attitudes among providers at NPF centers of excellence

    D. Bega, T. Simuni, M.S. Okun, P. Schmidt (Chicago, IL, USA)

    Objective: To gather data on the cannabis-related prescribing practices, and views regarding potential risks and benefits of cannabis, among experts caring for patients with PD.…
  • « Previous Page
  • 1
  • …
  • 1707
  • 1708
  • 1709
  • 1710
  • 1711
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley